 |
|
Effects of low-dose niacin on dyslipidemia and serum phosphorus in patients with chronic kidney disease
Hyo Jin Kang, Do Kyong Kim, Su Mi Lee, Kyung Han Kim, Seung Hee Han, Ki Hyun Kim, Seong Eun Kim, Young Ki Son, Won Suk An
Kidney Res Clin Pract. 2013;32(1):21-26. Published online 2012 Dec 31 DOI: https://doi.org/10.1016/j.krcp.2012.12.001
|
|
Citations to this article as recorded by
 Vitamin Supplement Use in Patients With CKD: Worth the Pill Burden?
Angela Yee-Moon Wang, Rengin Elsurer Afsar, Elizabeth J. Sussman-Dabach, Jennifer A. White, Helen MacLaughlin, T. Alp Ikizler
American Journal of Kidney Diseases.2024; 83(3): 370. CrossRef Oxidative balance score and associations with dyslipidemia and mortality among US adults: A mortality follow‐up study of a cross‐sectional cohort
Xiufang Kong, Xinghui Gao, Wei Wang
Journal of Parenteral and Enteral Nutrition.2024; 48(6): 735. CrossRef Changes in glucose metabolism, C-reactive protein, and liver enzymes following intake of NAD + precursor supplementation: a systematic review and meta‐regression analysis
Mohammad Hassan Sohouli, Sogand Tavakoli, Marcela Gomes Reis, Azita Hekmatdoost, Nathalia Sernizon Guimarães
Nutrition & Metabolism.2024;[Epub] CrossRef Does Vitamin Supplementation Play a Role in Chronic Kidney Disease?
Aleksandra Beata Juszczak, Maciej Kupczak, Tomasz Konecki
Nutrients.2023; 15(13): 2847. CrossRef Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease
Alla Mitrofanova, Sandra Merscher, Alessia Fornoni
Nature Reviews Nephrology.2023; 19(10): 629. CrossRef NAD+ Metabolism and Interventions in Premature Renal Aging and Chronic Kidney Disease
Lucie Chanvillard, Alessandra Tammaro, Vincenzo Sorrentino
Cells.2022; 12(1): 21. CrossRef Niasin Dislipidemi Riskini Azaltmada Potansiyel Bir Ajan Mıdır?
Taygun DAYI, Mustafa HOCA
İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi.2022; (17): 626. CrossRef Roles of NAD+ in Acute and Chronic Kidney Diseases
Marya Morevati, Evandro Fei Fang, Maria L. Mace, Mehmet Kanbay, Eva Gravesen, Anders Nordholm, Søren Egstrand, Mads Hornum
International Journal of Molecular Sciences.2022; 24(1): 137. CrossRef
NAD
+
homeostasis in human health and disease
Rubén Zapata‐Pérez, Ronald J A Wanders, Clara D M van Karnebeek, Riekelt H Houtkooper
EMBO Molecular Medicine.2021;[Epub] CrossRef NAD+ homeostasis in health and disease
Elena Katsyuba, Mario Romani, Dina Hofer, Johan Auwerx
Nature Metabolism.2020; 2(1): 9. CrossRef The effect of chronic kidney disease on lipid metabolism
Neris Dincer, Tuncay Dagel, Baris Afsar, Adrian Covic, Alberto Ortiz, Mehmet Kanbay
International Urology and Nephrology.2019; 51(2): 265. CrossRef Pleiotropic effects of niacin: Current possibilities for its clinical use
Miroslav Zeman, Marek Vecka, František Perlík, Barbora Staňková, Robert Hromádka, Eva Tvrzická, Jakub Širc, Jakub Hrib, Aleš Žák
Acta Pharmaceutica.2016; 66(4): 449. CrossRef Verminderung der Progression einer chronischen Niereninsuffizienz
D. Sollinger, B. Schamberger, J. Weinmann-Menke, J. Lutz
Der Nephrologe.2016; 11(4): 260. CrossRef Niacin
Reactions Weekly.2015; 1534(1): 135. CrossRef Niacin in patients with chronic kidney disease: Is it effective and safe?
Cheol Whee Park
Kidney Research and Clinical Practice.2013; 32(1): 1. CrossRef
|